Top Story

Azithromycin ineffectively treats macrolide-resistant M. genitalium

May 3, 2015

Azithromycin appeared to have a high rate of failure among patients infected with Mycoplasma genitalium who demonstrated pre-treatment macrolide resistance, according to recent findings.

Researchers evaluated 155 adult patients treated for M. genitalium infection between July 2012 and June 2013 at the Melbourne Sexual Health Centre in Victoria, Australia. Patients had their infection diagnosed through quantitative PCR and were treated with first-line azithromycin. All were instructed to forgo sexual activity for 14 days and to return for repeat testing between 14 and 28 days after therapy.

David A. Fleming, MD Meeting News Coverage

Experts from ABMS, ABIM discuss role of MOC at ACP Internal Medicine Meeting

May 2, 2015
BOSTON — Today at the ACP Internal Medicine Meeting, experts from the American Board of Medical Specialties and the American Board of Internal Medicine, discussed…
In the Journals

Possible sexual transmission of Ebola reported months after illness

May 1, 2015
Unprotected sex between a man discharged from an Ebola treatment unit 5 months earlier and a Liberian woman appears to have resulted in transmission of the virus…

Fifth patient dosed with 'one-shot' drug in HCV trial

May 1, 2015
The fifth and final patient in the phase 1/2a clinical trial of TT-034, a ddRNAi-based therapeutic to treat hepatitis C virus infection, has been dosed, according to a…
In the Journals

C. difficile infection remains among most costly, morbid nosocomial infections

May 1, 2015
Recent advances have been achieved in the prevention and treatment of Clostridium difficile infection, but it continues to be the most frequently reported nosocomial…
More News Headlines »
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
Meeting News Coverage Video
VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

April 24, 2015
BETHESDA, Md. — Richard K. Zimmerman, MD, of the University of Pittsburgh, explains the results of his study…
More »

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »